Despite the evidence indicating that NFκB may be involved in the glucose metabolism abnormalities and muscle wasting seen with certain pathologic conditions (e.g., type 2 diabetes, cancer, denervation, and disuse), it is not known whether NFκB is a link between the pathogenesis of insulin resistance and the muscle atrophy of aging. The gene discussed is NFKB1; the disease is Insulin resistance.